ATE335739T1 - Cak inhibitoren und deren verwendungen - Google Patents

Cak inhibitoren und deren verwendungen

Info

Publication number
ATE335739T1
ATE335739T1 AT02729350T AT02729350T ATE335739T1 AT E335739 T1 ATE335739 T1 AT E335739T1 AT 02729350 T AT02729350 T AT 02729350T AT 02729350 T AT02729350 T AT 02729350T AT E335739 T1 ATE335739 T1 AT E335739T1
Authority
AT
Austria
Prior art keywords
cak
inhibitors
compositions
relates
present
Prior art date
Application number
AT02729350T
Other languages
English (en)
Inventor
Brian Ledford
Cameron Stuver Moody
Michael Mullican
Mark Namchuk
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharma filed Critical Vertex Pharma
Application granted granted Critical
Publication of ATE335739T1 publication Critical patent/ATE335739T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
AT02729350T 2001-06-06 2002-06-06 Cak inhibitoren und deren verwendungen ATE335739T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29623901P 2001-06-06 2001-06-06

Publications (1)

Publication Number Publication Date
ATE335739T1 true ATE335739T1 (de) 2006-09-15

Family

ID=23141198

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02729350T ATE335739T1 (de) 2001-06-06 2002-06-06 Cak inhibitoren und deren verwendungen

Country Status (7)

Country Link
US (1) US7078209B2 (de)
EP (1) EP1399442B1 (de)
JP (1) JP2005501009A (de)
AT (1) ATE335739T1 (de)
DE (1) DE60213802T2 (de)
ES (1) ES2266497T3 (de)
WO (1) WO2002098876A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2838123B1 (fr) * 2002-04-04 2005-06-10 Sanofi Synthelabo Nouveaux derives d'indolozine-1,2,3 substituee, inhibiteurs selectifs du b-fgf
FR2859997B1 (fr) * 2003-09-18 2006-02-03 Sanofi Synthelabo Nouveaux derives d'indolizine 1,2,3,6,7,8 substituee, inhibiteurs des fgfs, leur procede de preparation et les compositions pharmaceutiques les contenant.
AU2006248812B2 (en) * 2005-05-18 2012-02-16 F2G Ltd Antifungal agents
GB0623209D0 (en) 2006-11-21 2007-01-03 F2G Ltd Antifungal agents
GB0710121D0 (en) 2007-05-25 2007-07-04 F2G Ltd Antifungal agents
JP5657524B2 (ja) 2008-04-24 2015-01-21 エフツージー リミテッド ピロール抗真菌剤
JP2014515368A (ja) 2011-05-26 2014-06-30 第一三共株式会社 プロテインキナーゼ阻害剤としての複素環化合物
CA2885259A1 (en) 2012-10-04 2014-04-10 Pfizer Limited Pyrrolo[3,2-c]pyridine tropomyosin-related kinase inhibitors
PL3221308T3 (pl) 2014-11-21 2019-03-29 F2G Limited Środki przeciwgrzybicze
GB201609222D0 (en) 2016-05-25 2016-07-06 F2G Ltd Pharmaceutical formulation
CN106632322B (zh) * 2016-12-20 2018-08-03 南京师范大学 一类吡唑中氮茚化合物及其制备方法与用途
US11819503B2 (en) 2019-04-23 2023-11-21 F2G Ltd Method of treating coccidioides infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3913682A1 (de) * 1989-04-26 1990-10-31 Bayer Ag 3-aryl-pyrrolidin-2,4-dione
AU622330B2 (en) 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
US5705350A (en) * 1995-08-29 1998-01-06 Duke University Transcription factor complexes in senescent cells

Also Published As

Publication number Publication date
EP1399442B1 (de) 2006-08-09
DE60213802T2 (de) 2007-03-29
US7078209B2 (en) 2006-07-18
US20030119793A1 (en) 2003-06-26
DE60213802D1 (de) 2006-09-21
WO2002098876A1 (en) 2002-12-12
ES2266497T3 (es) 2007-03-01
JP2005501009A (ja) 2005-01-13
EP1399442A1 (de) 2004-03-24

Similar Documents

Publication Publication Date Title
EP1615914A4 (de) Cgrp-rezeptorantagonisten
ATE433447T1 (de) Pyrimiidinverbindungen
SE0101675D0 (sv) Novel composition
DE60142921D1 (de) Azaphenanthridone-derivate und deren verwendung als parp-inhibitoren
BG66084B1 (bg) Циклопентаноиндоли, състави,съдържащи такива съединения и използването им
EA200401157A1 (ru) N-аминоацетилпирролидин-2-карбонитрилы и их применение в качестве ингибиторов ddp-iv
ATE433973T1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
DE60214703D1 (de) Thiazolverbindungen, die sich als inhibitoren von proteinkinasen eignen
PL406680A1 (pl) Inhibitory kinaz tyrozynowych
MXPA04004301A (es) Bencimidazoles sustituidos utiles como inhibidores de la proteina cinasa.
ATE433980T1 (de) Gyraseinhibitoren und deren verwendungen
ATE417051T1 (de) Polymorphe von clopidogrel-hydrogensulfat
BRPI0413234A (pt) derivados de imidazola bicìclica contra flaviviridae
ATE413388T1 (de) Muskarin antagonisten
DE60214179D1 (de) IMIDAZOi1,2-AöPYRIDIN-DERIVATE ZUR PROPHYLAXE UND BEHANDLUNG VON HERPES-INFEKTIONEN
EA200870391A1 (ru) Тетрагидропирролопиримидиндионы и их применение в качестве ингибиторов эластазы нейтрофилов человека
ES2243579T3 (es) Derivados de pirazolopirideno.
MXPA03011546A (es) Formulacion farmaceutica.
DE50208918D1 (de) 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
ATE349448T1 (de) Pyrazol-3,4-d-pyrimidinderivate und ihre verwendung bei der behandlung von h.pylori- infektionen
DE60213802D1 (de) Cak inhibitoren und deren verwendungen
DK1373220T3 (da) Benzimidazoler, som er nyttige ved behandling af seksuel dysfunktion
DE60329326D1 (de) Tace inhibitoren
BR0318521A (pt) arilindenopiridinas e arilindenopirimidinas e métodos terapêuticos e profiláticos relacionados
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties